Company intelligence / Profile preview
QuatRx Pharmaceuticals
Ann Arbor, Michigan, United Statesbiospace.com ↗
- Ownership
- Private
- Employees
- ~35
- Development stage
- Phase 3
01
Overview
QuatRx Pharmaceuticals focuses on discovering, licensing, developing, and commercializing therapies primarily targeting endocrine disorders associated with aging. Its lead asset ospemifene has completed Phase III trials for vulvar/vaginal atrophy and was submitted for regulatory approval via its global partner Shionogi Inc. Fispemifene targets testosterone deficiency in men and has reached Phase II. The company also developed becocalcidiol cream for psoriasis through a partnership with Collagenex. A cholesterol-lowering compound QRX‑431 entered early-stage clinical trials. The company’s management team has extensive experience bringing drugs to market.
- Therapeutic areas
- Women's HealthMen's HealthDermatologyCardiovascular
- Modalities
- Small molecules
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
Shionogi Inc. (global commercialization of ospemifene)Collagenex Pharmaceuticals (becocalcidiol cream development/commercialization partnership)
Beyond the preview
Go deeper on QuatRx Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on QuatRx Pharmaceuticals.